Autolus Therapeutics Ltd reported $11.12M in Interest Expense on Debt for its fiscal quarter ending in March of 2026.





Interest Expense On Debt Change Date
AstraZeneca USD 340M 144M Jun/2026
Autolus Therapeutics Ltd USD 11.12M 11.71M Mar/2026
Hikma Pharmaceutical USD 67M 47M Dec/2025
Novartis USD 462M 119M Jun/2026
Roche Holding CHF 304M 7.5M Jun/2025